Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

4.5K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imlunestrant plus abemaciclib versus fulvestrant plus abemaciclib in ER-positive, HER2-negative advanced breast cancer: an indirect treatment comparison of three phase III trials.

ESMO open·2026
Same author

Exploring the treatment gap and outcome risks in patients with node-positive, high-risk, HR-positive, HER2-negative early breast cancer: analyses of real-world data.

ESMO open·2026
Same author

A phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study.

ESMO open·2026
Same author

Imlunestrant with or without abemaciclib in advanced breast cancer: updated efficacy results from the phase III EMBER-3 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Surgical stage in the era of molecular profiling of endometrial cancer.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Overall survival with abemaciclib in early breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Related Experiment Video

Updated: May 1, 2026

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.2K

Postpartum breast cancer behaves differently.

N Van den Rul1, S N Han1, K Van Calsteren1

  • 1Multidisciplinary Breast Centre, Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium--

Facts, Views & Vision in Obgyn
|April 23, 2014
PubMed
Summary

Postpartum breast cancer (PPBC) shows a worse prognosis compared to non-pregnancy-associated breast cancer (PABC). This pilot study confirms PPBC is more aggressive, with lower survival rates.

Keywords:
Breast cancerMatched case-control studyPostpartumPrognosis

More Related Videos

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

5.8K
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

19.8K

Related Experiment Videos

Last Updated: May 1, 2026

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.2K
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

5.8K
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

19.8K

Area of Science:

  • Oncology
  • Reproductive Medicine
  • Clinical Epidemiology

Background:

  • Previous research indicates a poorer prognosis for postpartum breast cancer (PPBC).
  • Pregnancy-associated breast cancer (PABC) requires further investigation in diverse clinical settings.
  • Understanding PPBC outcomes is crucial for early detection and treatment strategies.

Purpose of the Study:

  • To investigate the hypothesis of a worse prognosis for PPBC diagnosed within 12 months postpartum.
  • To compare the disease outcomes of PPBC patients with a matched control group of non-PABC patients.
  • To evaluate survival rates in PPBC cases versus controls.

Main Methods:

  • A retrospective, multicentre, paired case-control study was conducted.
  • Breast cancer patients under 45 from the UZ Leuven database were analyzed.
  • Cases (PPBC) were matched with controls (non-PABC) based on age, tumor type, characteristics, and stage. Kaplan-Meier statistics were used for survival analysis.

Main Results:

  • 53 PPBC cases were matched with 103 controls.
  • All PPBC cases were invasive ductal carcinoma; 56.6% had lymph node involvement, and 13% were primary metastatic.
  • 5-year overall survival was 60% for PPBC versus 84% for controls; 5-year disease-free survival was 53% for PPBC versus 68% for controls.

Conclusions:

  • Postpartum breast cancer demonstrates more aggressive behavior compared to matched non-PABC cases.
  • Findings suggest a significantly worse prognosis for PPBC.
  • Further research with longer follow-up and larger cohorts is warranted to validate these results.